The scoping study, from what we discussed, has been completed. They engaged ASX to release it but they were rejected as the resource is "inferred" and as such can't be released under ASX rules. So the document remains internal for now, although gary assured me that he has engaged with their lawyers to see what parts of it can be released to market. He also assured me that they were very happy with the outcome and definitively decided to push on with the project based on the numbers. The metallurgy was part of the same report so was fruit of the poisonous tree accroding to the asx.
I may reach out again today to see how that is progressing regarding getting something to market.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities and Cashflow Report
The scoping study, from what we discussed, has been completed....
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.175M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 19454575 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 9763372 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2200000 | 0.006 |
9 | 8299899 | 0.005 |
6 | 3650000 | 0.004 |
3 | 2622888 | 0.003 |
3 | 4000100 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 2536904 | 6 |
0.008 | 3066187 | 5 |
0.009 | 1057001 | 6 |
0.010 | 5904545 | 3 |
0.011 | 500000 | 1 |
Last trade - 16.12pm 25/11/2024 (20 minute delay) ? |
Featured News
NAE (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online